UTMD
Income statement / Annual
Last year (2024), Utah Medical Products, Inc.'s total revenue was $40.90 M,
a decrease of 18.56% from the previous year.
In 2024, Utah Medical Products, Inc.'s net income was $13.87 M.
See Utah Medical Products, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$40.90 M |
$50.22 M |
$52.28 M |
$49.05 M |
$42.18 M |
$46.90 M |
$42.00 M |
$41.41 M |
$39.30 M |
$40.16 M |
| Cost of Revenue |
$16.76 M
|
$20.19 M
|
$20.09 M
|
$18.14 M
|
$16.63 M
|
$17.44 M
|
$15.69 M
|
$15.02 M
|
$15.61 M
|
$15.97 M
|
| Gross Profit |
$24.14 M
|
$30.04 M
|
$32.20 M
|
$30.92 M
|
$25.55 M
|
$29.47 M
|
$26.31 M
|
$26.40 M
|
$23.69 M
|
$24.19 M
|
| Gross Profit Ratio |
0.59
|
0.6
|
0.62
|
0.63
|
0.61
|
0.63
|
0.63
|
0.64
|
0.6
|
0.6
|
| Research and Development Expenses |
$813,000.00
|
$560,000.00
|
$493,000.00
|
$526,000.00
|
$486,000.00
|
$483,000.00
|
$454,000.00
|
$447,000.00
|
$475,000.00
|
$522,000.00
|
| General & Administrative Expenses |
$5.70 M
|
$11.02 M
|
$10.41 M
|
$10.10 M
|
$9.80 M
|
$9.61 M
|
$5.45 M
|
$5.39 M
|
$5.36 M
|
$5.85 M
|
| Selling & Marketing Expenses |
$1.90 M
|
$1.69 M
|
$1.51 M
|
$1.41 M
|
$1.55 M
|
$1.74 M
|
$1.71 M
|
$1.54 M
|
$1.67 M
|
$2.16 M
|
| Selling, General & Administrative Expenses |
$7.60 M
|
$12.70 M
|
$11.91 M
|
$11.51 M
|
$11.35 M
|
$11.35 M
|
$7.16 M
|
$6.94 M
|
$7.03 M
|
$8.01 M
|
| Other Expenses |
$2.14 M
|
$0.00
|
$208,000.00
|
$15,000.00
|
$20,000.00
|
-$2,000.00
|
$513,000.00
|
$54,000.00
|
$223,000.00
|
-$46,000.00
|
| Operating Expenses |
$10.55 M
|
$13.26 M
|
$12.41 M
|
$12.04 M
|
$11.84 M
|
$11.83 M
|
$7.61 M
|
$7.38 M
|
$7.50 M
|
$8.53 M
|
| Cost And Expenses |
$27.31 M
|
$33.45 M
|
$32.49 M
|
$18.14 M
|
$28.47 M
|
$29.27 M
|
$23.30 M
|
$22.40 M
|
$23.11 M
|
$24.51 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$166,000.00
|
$112,000.00
|
$254,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$65,000.00
|
| Depreciation & Amortization |
$2.77 M
|
$6.37 M
|
$7.08 M
|
$7.28 M
|
$7.21 M
|
$6.88 M
|
$2.96 M
|
$2.77 M
|
$2.83 M
|
$3.15 M
|
| EBITDA |
$18.50 M |
$24.75 M |
$26.87 M |
$26.16 M |
$20.92 M |
$24.51 M |
$21.65 M |
$21.78 M |
$19.02 M |
$18.84 M |
| EBITDA Ratio |
0.45
|
0.49
|
0.38
|
0.63
|
0.33
|
0.38
|
-0.45
|
0.53
|
0.6
|
0.6
|
| Operating Income Ratio |
0.33
|
0.33
|
0.24
|
0.38
|
0.15
|
0.23
|
0.45
|
0.46
|
0.41
|
0.39
|
| Total Other Income/Expenses Net |
$3.21 M
|
$3.31 M
|
$869,000.00
|
$181,000.00
|
$132,000.00
|
$252,000.00
|
$762,000.00
|
$71,000.00
|
$235,000.00
|
-$106,000.00
|
| Income Before Tax |
$16.80 M
|
$20.09 M
|
$20.66 M
|
$19.06 M
|
$13.84 M
|
$17.88 M
|
$19.46 M
|
$19.08 M
|
$16.42 M
|
$15.55 M
|
| Income Before Tax Ratio |
0.41
|
0.4
|
0.4
|
0.39
|
0.33
|
0.38
|
0.46
|
0.46
|
0.42
|
0.39
|
| Income Tax Expense |
$2.93 M
|
$3.45 M
|
$4.19 M
|
$4.27 M
|
$3.04 M
|
$3.16 M
|
$904,000.00
|
$10.58 M
|
$4.29 M
|
$3.70 M
|
| Net Income |
$13.87 M
|
$16.64 M
|
$16.47 M
|
$14.79 M
|
$10.80 M
|
$14.73 M
|
$18.55 M
|
$8.51 M
|
$12.13 M
|
$11.84 M
|
| Net Income Ratio |
0.34
|
0.33
|
0.32
|
0.3
|
0.26
|
0.31
|
0.44
|
0.21
|
0.31
|
0.29
|
| EPS |
3.96 |
4.57 |
4.53 |
4.05 |
2.95 |
3.96 |
4.97 |
2.29 |
3.22 |
3.14 |
| EPS Diluted |
3.96 |
4.57 |
4.52 |
4.04 |
2.94 |
3.94 |
4.95 |
2.28 |
3.22 |
3.14 |
| Weighted Average Shares Out |
$3.50 M
|
$3.64 M
|
$3.64 M
|
$3.65 M
|
$3.66 M
|
$3.72 M
|
$3.73 M
|
$3.72 M
|
$3.75 M
|
$3.77 M
|
| Weighted Average Shares Out Diluted |
$3.50 M
|
$3.64 M
|
$3.64 M
|
$3.66 M
|
$3.67 M
|
$3.74 M
|
$3.75 M
|
$3.74 M
|
$3.77 M
|
$3.77 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
